NCT03455335View on ClinicalTrials.gov

Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 23, 2015

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Critical Limb Ischemia
Interventions
DRUG

20 million hMSCs

DRUG

40 million hMSCs

DRUG

80 million hMSCs

Trial Locations (1)

0

Galway University Hospital, Galway

All Listed Sponsors
collaborator

University Hospital of Limerick

OTHER

lead

National University of Ireland, Galway, Ireland

OTHER

NCT03455335 - Autologous Stem Cells for the Treatment of No Option Critical Limb Ischemia | Biotech Hunter | Biotech Hunter